Pfizer, US Women's & Men's Health, Medical Affairs Lead, 235 E. 42nd St. New York City, NY 10016 United States.
Drug Discov Today. 2020 Mar;25(3):475-479. doi: 10.1016/j.drudis.2019.11.011. Epub 2019 Nov 29.
Within the biopharmaceutical environment there are increased expectations for medical affairs to serve as a patient understanding facilitator, engagement champion and empowerment enabler. The collaborative development of a medical affairs patient-centricity framework to characterize avenues of medical affairs patient-centric activity could enhance transparency of objectives, input and outputs of medical affairs interactions with the patient. This article presents an initial opinion regarding how medical affairs interacts with patients to advance patient centricity. The proposal: medical affairs engages and collaborates with patients through strategic leadership, medical communication, evidence generation, patient engagement and experience of patient care. Once validated, such a framework's implementation could help clarify medical affairs competencies and behaviors necessary to optimize associated effort.
在生物制药环境中，人们对医学事务提出了更高的要求，期望它能够充当患者理解的促进者、参与的拥护者和赋权的推动者。合作制定一个以患者为中心的医学事务框架，以描述医学事务以患者为中心的活动途径，可以提高医学事务与患者互动的目标、投入和产出的透明度。本文初步探讨了医学事务如何与患者互动以推进以患者为中心的理念。建议：医学事务通过战略领导力、医学沟通、证据生成、患者参与和患者护理体验与患者进行互动和合作。一旦得到验证，这种框架的实施可以帮助澄清优化相关工作所需的医学事务能力和行为。
